Ivermectin/Pyrantel Pamoate

Verify with FDA CVM →

135 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
135
Total Reports
4
Deaths Reported
300.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel Pamoate

Administration Routes

OralUnknown

Species Affected

Dog 135

Most Affected Breeds

Retriever - Labrador 23
Crossbred Canine/dog 13
Shepherd Dog - German 9
Retriever - Golden 8
Beagle 7
Shepherd Dog - Australian 6
Boxer (German Boxer) 5
Greyhound 5
Terrier (unspecified) 4
Rottweiler 4

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 49
Lack of efficacy (endoparasite) - heartworm 13
Diarrhoea 12
INEFFECTIVE, HOOKS 12
Lack of efficacy - NOS 10
Vomiting 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Lack of efficacy (endoparasite) - hookworm 7
Anorexia 6
Underdose 5
Emesis 5
Emesis (multiple) 5

Outcome Breakdown

Outcome Unknown
53 (39.3%)
Ongoing
42 (31.1%)
Recovered/Normal
36 (26.7%)
Euthanized
3 (2.2%)
Died
1 (0.7%)

Data Summary

Metric Value
Total adverse event reports 135
Reports involving death 4
Case-fatality rate (reported events) 300.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 135 adverse event reports referencing Ivermectin/Pyrantel Pamoate, including 4 reports in which the animal died — a 300.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Pamoate. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel Pamoate reports are Dog (135 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (23), Crossbred Canine/dog (13), Shepherd Dog - German (9) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel Pamoate are INEFFECTIVE, HEARTWORM LARVAE (49), Lack of efficacy (endoparasite) - heartworm (13), Diarrhoea (12), INEFFECTIVE, HOOKS (12). Of the 135 reports with a coded outcome, Outcome Unknown is the leading category at 39.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial